Related Experiment Video
Updated: Nov 29, 2025

Author Spotlight: Optimization of Ultrashort Peptide Matrices for Colorectal Cancer Organoids
Published on: May 3, 2024
Cell primitive-based biomimetic functional materials for enhanced cancer therapy
Guo-Feng Luo1, Wei-Hai Chen, Xuan Zeng
1Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan 430072, P. R. China. xz-zhang@whu.edu.cn.
Innovative functional materials combining natural cell primitives and nanotechnology show promise for advanced cancer therapy. These hybrid biomaterials offer enhanced targeting, drug delivery, and immune modulation for precise treatment.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Cancer Therapeutics
Background:
- Cell primitives offer unique biological functions like tumor targeting and immune modulation.
- Synthetic nanomaterials provide effective drug delivery and anticancer properties.
- Combining these creates advanced biomaterials for cancer treatment.
Purpose of the Study:
- To review recent advances in cell primitive-based functional materials for cancer therapy.
- To explore strategies for combining cell primitives with synthetic nanomaterials.
- To discuss future challenges and perspectives in this field.
Main Methods:
- Literature review of cell primitive-based functional materials.
- Analysis of different cell primitives (bacteria, phages, cells, cell membranes).
- Summary of strategies for integrating cell primitives with nanoparticulate systems.
Main Results:
- Cell primitive-nanomaterial hybrids exhibit enhanced biocompatibility and reduced immunogenicity.
- These materials demonstrate potential for multi-functional cancer therapy.
- Recent developments show promise in precise tumor targeting and drug delivery.
Conclusions:
- Cell primitive-based functional materials represent a promising frontier in cancer therapy.
- Integration with nanotechnology enhances their therapeutic efficacy and specificity.
- Further research is needed to address challenges and unlock full potential.
More Related Videos
08:02Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
10:513D Cell-Printed Hypoxic Cancer-on-a-Chip for Recapitulating Pathologic Progression of Solid Cancer
Published on: January 5, 2021
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...